Wednesday, 14 Nov 2018

You are here

RheumNow Week in Review – Medical School Advice (9.7.18)

Dr. Jack Cush reviews news and journal articles from the past week on RheumNow.com.

  1. Methotrexate's Low Efficacy in Cutaneous Psoriasis  
  2. Usual Allopurinol Doses Insufficient in CKD Patients  
  3. Tocilizumab Equals other Biologics in Cardiovascular Risk  
  4. CRA Recommendations for Lupus Assessment and Monitoring 
  5. Advice for a Student starting Medical School - 3 important lessons: 1) Often the most important thing we give a patient is not what we think it is; 2) Much of what you are taught is wrong; 3) Keep a sunshine folder. #SGU White Coat ceremony https://t.co/jI9KdNaGXY

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

MMWR: Death by Firearms

The CDC's Morbidity and Mortality Weekly Report (MMWR) reports that during 2015–2016 there was a total of 27,394 firearm homicides and 44,955 firearm suicides among US residents, with 12% and 5% of events occuring in children 10–19 years.

RheumNow Weekly Podcast – 3 Wiseguy Rheumatologists (11.9.18)

Dr Jack Cush reviews the News and Journal reports from the past week on RheumNow.com.  Be sure to check out our upcoming meeting in March 2019 - RheumNow Live.

E/M Guidelines: Right Road, Wrong Direction

Last July, the Centers for Medicare & Medicaid Services (CMS) proposed new E/M guidelines for office visits with physicians. It issued the final guidelines on November 1, with a few tweaks. Implementation was delayed until 2021 (from 2019), possibly due to overwhelming opposition from physicians.

RheumNow Week in Review – The Heart Attack Report (11.2.18)

Dr Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

'These Results Are Astonishing': What We Heard at ACR 2018

"If radiation was a drug that could improve survival in the metastatic setting like that it would be millions and millions of dollars." -- James B. Yu, of Yale Cancer Center, discussing aggressive use of stereotactic body radiation therapy in oligometastatic cancer.

*******************************************************